Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

M Filippi, P Preziosa, BL Banwell, F Barkhof… - Brain, 2019 - academic.oup.com
MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image
interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some …

Tumefactive demyelination in MOG Ab–associated disease, multiple sclerosis, and AQP-4-IgG–positive neuromyelitis optica spectrum disorder

L Cacciaguerra, P Morris, WO Tobin, JJ Chen… - Neurology, 2023 - AAN Enterprises
Background and Objectives Studies on tumefactive brain lesions in myelin oligodendrocyte
glycoprotein-immunoglobulin G (IgG)–associated disease (MOGAD) are lacking. We sought …

[HTML][HTML] Role of artificial intelligence in MS clinical practice

R Bonacchi, M Filippi, MA Rocca - NeuroImage: Clinical, 2022 - Elsevier
Abstract Machine learning (ML) and its subset, deep learning (DL), are branches of artificial
intelligence (AI) showing promising findings in the medical field, especially when applied to …

Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model

JM Seok, W Cho, YH Chung, H Ju, ST Kim, JK Seong… - Scientific reports, 2023 - nature.com
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are
autoimmune inflammatory disorders of the central nervous system (CNS) with similar …

Neuromyelitis optica spectrum disorders

F Costello - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article reviews the cardinal clinical features, distinct
immunopathology, current diagnostic criteria, relapse-related risk factors, emerging …

Neuroimaging features in inflammatory myelopathies: a review

L Cacciaguerra, E Sechi, MA Rocca, M Filippi… - Frontiers in …, 2022 - frontiersin.org
Spinal cord involvement can be observed in the course of immune-mediated disorders.
Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy …

Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017–continuity and change

HP Hartung, J Graf, O Aktas, J Mares… - Current opinion in …, 2019 - journals.lww.com
Diagnosis of multiple sclerosis: revisions of the McDonald c... : Current Opinion in Neurology
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 – continuity and …

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

R Cortese, M Battaglini, F Prados, A Bianchi, L Haider… - Brain, 2023 - academic.oup.com
MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease
may overlap with those of other inflammatory demyelinating conditions posing diagnostic …

Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG-and MOG-IgG-associated diseases

S Mader, T Kümpfel, E Meinl - Current Opinion in Neurology, 2020 - journals.lww.com
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …